Key facts
- This page summarizes Samir R. Patel's Form 4 filing for Akari Therapeutics Plc (AKTX).
- 2 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 07 Jan 2025, 16:30.
Samir R. Patel - 03 Jan 2025 Form 4 Insider Report for Akari Therapeutics Plc (AKTX)
- Reporting relationship
- Director
- Issuer ticker
- AKTX
- Reported as of
- 03 Jan 2025
- Net transaction value
- +$125
- SEC form
- 4
- Accepted by SEC
- 07 Jan 2025, 16:30:03 UTC
- Prior SEC filing
- 30 Dec 2024
- Next SEC filing
- 10 Mar 2025
- Source filing
- View source filing
- Reporting owner signature
- /s/ Torsten Hombeck, as Attorney-in-Fact
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Samir R. Patel filed Form 4 for Akari Therapeutics Plc (AKTX) on 07 Jan 2025.
Change
- Previous filing in this sequence was filed on 30 Dec 2024.
- Current net transaction value: +$125.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
AKTX
transaction
Ordinary Shares, par value $0.0001 per share
Award
- Transaction value
- $125
- Shares
- +208,000
- Change %
- +0%
- Price
- $0.000600
- Shares after
- 5,249,511,500
- Date
- 03 Jan 2025
- Ownership
- PranaBio Investments LLC
- Footnotes
- F1, F2
AKTX
holding
Ordinary Shares, par value $0.0001 per share
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 91,396,000
- Date
- 03 Jan 2025
- Ownership
- Direct
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
AKTX
transaction
Derivative
Stock Option (Right to Buy)
Award
- Transaction value
- $0
- Shares
- +152,672,000
- Change %
- Price
- $0.000000
- Shares after
- 152,672,000
- Date
- 03 Jan 2025
- Ownership
- Direct
- Underlying class
- Ordinary Shares, par value $0.0001 per share
- Underlying amount
- 152,672,000
- Exercise price
- $0.000600
- Footnotes
- F1, F3
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 3 footnotes
Footnote F1
The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents 2,000 Ordinary Shares.
Footnote F2
On January 3, 2025, the Reporting Person acquired 208,000 Ordinary Shares at a purchase price of $0.0006 per Ordinary Share.
Footnote F3
The stock options have an exercise price of $0.000655 per Ordinary Share.